Header Logo

Connection

KETANKUMAR GHAGHADA to Animals

Back to Details
This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Animals.
KETANKUMAR GHAGHADA
Connection Strength
0.774
Animals
  1. Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb; 17(1):e70004.
    View in: PubMed
    Score: 0.052
  2. Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research. Methods Mol Biol. 2022; 2419:809-823.
    View in: PubMed
    Score: 0.042
  3. Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
    View in: PubMed
    Score: 0.039
  4. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
    View in: PubMed
    Score: 0.038
  5. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
    View in: PubMed
    Score: 0.036
  6. Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. Phys Med Biol. 2019 03 12; 64(6):065007.
    View in: PubMed
    Score: 0.035
  7. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
    View in: PubMed
    Score: 0.031
  8. Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
    View in: PubMed
    Score: 0.029
  9. Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer. PLoS One. 2016; 11(3):e0152718.
    View in: PubMed
    Score: 0.028
  10. Crossing the barrier: treatment of brain tumors using nanochain particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 09; 8(5):678-95.
    View in: PubMed
    Score: 0.028
  11. Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
    View in: PubMed
    Score: 0.022
  12. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012; 7(4):e34496.
    View in: PubMed
    Score: 0.021
  13. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011 Jan; 18(1):20-30.
    View in: PubMed
    Score: 0.020
  14. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
    View in: PubMed
    Score: 0.018
  15. High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007 Jan; 28(1):48-53.
    View in: PubMed
    Score: 0.015
  16. Immature Acta2R179C/+ smooth muscle cells cause moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS. Nat Commun. 2025 Jul 02; 16(1):6105.
    View in: PubMed
    Score: 0.013
  17. Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
    View in: PubMed
    Score: 0.013
  18. Assessing the cardioprotective effects of exercise in APOE mouse models using deep learning and photon-counting micro-CT. PLoS One. 2025; 20(4):e0320892.
    View in: PubMed
    Score: 0.013
  19. Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models. Arterioscler Thromb Vasc Biol. 2025 May; 45(5):609-631.
    View in: PubMed
    Score: 0.013
  20. Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
    View in: PubMed
    Score: 0.013
  21. Advanced photon counting CT imaging pipeline for cardiac phenotyping of apolipoprotein E mouse models. PLoS One. 2023; 18(10):e0291733.
    View in: PubMed
    Score: 0.012
  22. Micro-CT imaging of multiple K-edge elements using GaAs and CdTe photon counting detectors. Phys Med Biol. 2023 04 12; 68(8).
    View in: PubMed
    Score: 0.011
  23. Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
    View in: PubMed
    Score: 0.011
  24. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
    View in: PubMed
    Score: 0.011
  25. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
    View in: PubMed
    Score: 0.011
  26. MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat Commun. 2022 06 28; 13(1):3728.
    View in: PubMed
    Score: 0.011
  27. Photon Counting CT and Radiomic Analysis Enables Differentiation of Tumors Based on Lymphocyte Burden. Tomography. 2022 03 10; 8(2):740-753.
    View in: PubMed
    Score: 0.011
  28. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.010
  29. miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
    View in: PubMed
    Score: 0.010
  30. Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
    View in: PubMed
    Score: 0.009
  31. Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture. Circulation. 2020 01 07; 141(1):42-66.
    View in: PubMed
    Score: 0.009
  32. Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors. Mol Pharm. 2019 10 07; 16(10):4352-4360.
    View in: PubMed
    Score: 0.009
  33. Delivery of drugs into brain tumors using multicomponent silica nanoparticles. Nanoscale. 2019 Jun 20; 11(24):11910-11921.
    View in: PubMed
    Score: 0.009
  34. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
    View in: PubMed
    Score: 0.009
  35. NIR-II fluorescence imaging using indocyanine green nanoparticles. Sci Rep. 2018 09 27; 8(1):14455.
    View in: PubMed
    Score: 0.008
  36. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
    View in: PubMed
    Score: 0.008
  37. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
    View in: PubMed
    Score: 0.008
  38. Indocyanine green fluorescence in second near-infrared (NIR-II) window. PLoS One. 2017; 12(11):e0187563.
    View in: PubMed
    Score: 0.008
  39. A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
    View in: PubMed
    Score: 0.007
  40. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
    View in: PubMed
    Score: 0.007
  41. Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent. Sci Rep. 2015 May 18; 5:10178.
    View in: PubMed
    Score: 0.007
  42. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Res. 2015 Apr 01; 75(7):1356-65.
    View in: PubMed
    Score: 0.006
  43. Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev. 2014 Sep 30; 76:79-97.
    View in: PubMed
    Score: 0.006
  44. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release. 2014 Jan 10; 173:51-8.
    View in: PubMed
    Score: 0.006
  45. Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano. 2013 Apr 23; 7(4):3118-29.
    View in: PubMed
    Score: 0.006
  46. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
    View in: PubMed
    Score: 0.006
  47. High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):18-22.
    View in: PubMed
    Score: 0.005
  48. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
    View in: PubMed
    Score: 0.005
  49. High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent. Magn Reson Med. 2009 Dec; 62(6):1447-56.
    View in: PubMed
    Score: 0.005
  50. Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine. 2009; 4:277-82.
    View in: PubMed
    Score: 0.004
  51. Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol. 2007 Mar; 14(3):355-62.
    View in: PubMed
    Score: 0.004
  52. Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med. 2006 May; 55(5):1023-9.
    View in: PubMed
    Score: 0.004
  53. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006 Feb; 186(2):300-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.